Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2011-10-24 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Change in substantial holding 4 pages 100.1KB
Regulatory Filings
2011-10-24 English
Share Purchase Plan documentation 12 pages 108.8KB
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement and accompanying documentation for a Share Purchase Plan (SPP) by Phosphagenics Limited. It includes the offer terms, timetable, eligibility criteria, pricing, and instructions for shareholders to participate in the plan. The content focuses on the issuance of new shares to existing shareholders under a specific plan, including details about the discount, scale back, and application process. This is a capital raising activity involving the issuance of new shares, which fits the definition of a Capital/Financing Update (CAP). The document is not a full financial report, earnings release, or regulatory filing but a specific announcement and detailed documentation related to a share capital raising event.
2011-10-23 English
Successful $24.1m Capital Raising and $3m SPP 9 pages 110.1KB
Capital/Financing Update Classification · 100% confidence The document is a company announcement detailing a capital raising event by Phosphagenics Limited, including a $24.1 million placement and a $3 million share purchase plan (SPP). It includes specifics about the number of shares issued, pricing, purpose of the capital raising, and shareholder approval requirements. The document also contains an Appendix 3B, which is a standard ASX form for new issue announcements and applications for quotation of additional securities. The content focuses on fundraising activities and share issuance rather than financial results, management commentary, or regulatory certifications. The length of the document (over 14,000 characters) and detailed information about the capital raising and share issuance confirm it is not a brief announcement or a report publication notice. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2011-10-20 English
Share Purchase Plan - Notice under ASIC CO 09-425 1
Capital/Financing Update Classification · 95% confidence The document is a notice under ASIC Class Order 09/425 regarding a Share Purchase Plan. It announces the company's intention to issue shares under the plan without disclosure to investors under specific provisions of the Corporations Act. The document is short (1314 characters) and serves as an announcement of a capital raising activity rather than the detailed report or plan itself. Therefore, it fits the category of Capital/Financing Update (CAP).
2011-10-20 English
Trading halt 2 pages 54.2KB
Regulatory Filings Classification · 95% confidence The document is a market release dated 19 October 2011 from Phosphagenics Limited announcing a trading halt requested by the company pending a significant funding-related announcement. The text explicitly states the halt is requested under Listing Rule 17.1 and that the announcement is expected before market opening on 21 October 2011. The document does not contain any financial data, report content, or detailed disclosures but is a regulatory announcement about trading status. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories like Capital/Financing Update (CAP) because it does not provide the funding details themselves, only the halt pending such announcement.
2011-10-18 English
Legacy Executes Share Subscriotion Agreement with NMDC 7 pages 119.1KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 18 October 2011 from Legacy Iron Ore Limited, detailing a Share Subscription Agreement with NMDC. It discusses a placement of shares, financing arrangements, project development plans, and upcoming shareholder meetings to approve the placement. The content focuses on capital raising, financing, and strategic investment activities rather than financial results, management changes, or regulatory certifications. The document is lengthy (15,000 characters) and contains detailed information about the financing agreement and related corporate actions. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. It is not an Annual Report, Earnings Release, or Regulatory Filing, nor is it a simple announcement of a report publication. Therefore, the appropriate classification is CAP with high confidence.
2011-10-17 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.